. 2021 Oct 19;2021:3025848. doi: 10.1155/2021/3025848

Table 2.

Antibacterial activity of DCM extract against P. aeruginosa, E. coli, B. subtilis, and S. aureus.

Treatment	Zones of inhibition (mm)
Treatment	P. aeruginosa	E. coli	B. subtilis	S. aureus
200 mg/ml	10.67 ± 0.58^b	7.67 ± 0.58^b	10.33 ± 1.15^b	9.33 ± 0.58^b
100 mg/ml	10.67 ± 0.58^b	6.50 ± 0.50^bc	9.33 ± 1.15^b	9.33 ± 0.58^b
50 mg/ml	10.33 ± 0.58^b	6.50 ± 0.50^bc	9.00 ± 1.00^b	9.33 ± 0.58^b
25 mg/ml	9.67 ± 0.58^b	6.33 ± 0.58^bcd	9.00 ± 1.00^b	8.67 ± 0.58^bc
12.5 mg/ml	9.33 ± 0.58^b	6.33 ± 0.58^bcd	8.33 ± 0.58^b	8.33 ± 0.58^bc
6.25 mg/ml	7.33 ± 0.58^c	5.83 ± 0.29^cd	8.33 ± 0.58^b	7.67 ± 0.58^c
Negative control	5.00 ± 0.00^d	5.00 ± 0.00^d	5.00 ± 0.00^c	5.00 ± 0.00^d
Ciprofloxacin	19.33 ± 0.58^a	32.67 ± 0.58^a	20.67 ± 0.58^a	14.00 ± 0.00^a

Descriptive statistics expressed as mean ± standard deviation for three replicates. Values with the same letter along the column are not significantly different by one-way ANOVA followed by Bonferroni post hoc test (p > 0.05).